Visual outcome following initiation of first injection versus after three monthly doses of aflibercept 2 mg for treatment naïve age-related macular degeneration to inform clinical trial designs: PRECISE Report No. 6
首次注射阿柏西普 2 mg 与连续三个月每月注射阿柏西普 2 mg 治疗初治年龄相关性黄斑变性患者的视觉结果比较，旨在为临床试验设计提供依据：PRECISE 报告第 6 号
期刊:
影响因子:
doi:10.1038/s41433-025-03797-z
Chandak, Swati; Gurudas, Sarega; Pakeer Muhammed, Raheeba; Keskin, Ayse; Thottarath, Sridevi; Ghanchi, Faruque; Grabowska, Anna; Talks, Stephen James; Pearce, Ian; McKibbin, Martin; Kotagiri, Ajay; Menon, Geeta; Burton, Benjamin J L; Gale, Richard; Sivaprasad, Sobha
